Cargando…
Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges
The cerebellum is particularly enriched in antigens and represents a vulnerable target to immune attacks. Immune-mediated cerebellar ataxias (IMCAs) have diverse etiologies, such as gluten ataxia (GA), post-infectious cerebellitis (PIC), Miller Fisher syndrome (MFS), paraneoplastic cerebellar degene...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496914/ https://www.ncbi.nlm.nih.gov/pubmed/36138901 http://dx.doi.org/10.3390/brainsci12091165 |
_version_ | 1784794388032913408 |
---|---|
author | Hadjivassiliou, Marios Manto, Mario Mitoma, Hiroshi |
author_facet | Hadjivassiliou, Marios Manto, Mario Mitoma, Hiroshi |
author_sort | Hadjivassiliou, Marios |
collection | PubMed |
description | The cerebellum is particularly enriched in antigens and represents a vulnerable target to immune attacks. Immune-mediated cerebellar ataxias (IMCAs) have diverse etiologies, such as gluten ataxia (GA), post-infectious cerebellitis (PIC), Miller Fisher syndrome (MFS), paraneoplastic cerebellar degeneration (PCD), opsoclonus myoclonus syndrome (OMS), and anti-GAD ataxia. Apart from these well-established entities, cerebellar ataxia (CA) occurs also in association with autoimmunity against ion channels and related proteins, synaptic adhesion/organizing proteins, transmitter receptors, glial cells, as well as the brainstem antigens. Most of these conditions manifest diverse neurological clinical features, with CAs being one of the main clinical phenotypes. The term primary autoimmune cerebellar ataxia (PACA) refers to ataxic conditions suspected to be autoimmune even in the absence of specific well-characterized pathogenic antibody markers. We review advances in the field of IMCAs and propose a clinical approach for the understanding and diagnosis of IMCAs, focusing on rare etiologies which are likely underdiagnosed. The frontiers of PACA are discussed. The identification of rare immune ataxias is of importance since they are potentially treatable and may lead to a severe clinical syndrome in absence of early therapy. |
format | Online Article Text |
id | pubmed-9496914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94969142022-09-23 Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges Hadjivassiliou, Marios Manto, Mario Mitoma, Hiroshi Brain Sci Review The cerebellum is particularly enriched in antigens and represents a vulnerable target to immune attacks. Immune-mediated cerebellar ataxias (IMCAs) have diverse etiologies, such as gluten ataxia (GA), post-infectious cerebellitis (PIC), Miller Fisher syndrome (MFS), paraneoplastic cerebellar degeneration (PCD), opsoclonus myoclonus syndrome (OMS), and anti-GAD ataxia. Apart from these well-established entities, cerebellar ataxia (CA) occurs also in association with autoimmunity against ion channels and related proteins, synaptic adhesion/organizing proteins, transmitter receptors, glial cells, as well as the brainstem antigens. Most of these conditions manifest diverse neurological clinical features, with CAs being one of the main clinical phenotypes. The term primary autoimmune cerebellar ataxia (PACA) refers to ataxic conditions suspected to be autoimmune even in the absence of specific well-characterized pathogenic antibody markers. We review advances in the field of IMCAs and propose a clinical approach for the understanding and diagnosis of IMCAs, focusing on rare etiologies which are likely underdiagnosed. The frontiers of PACA are discussed. The identification of rare immune ataxias is of importance since they are potentially treatable and may lead to a severe clinical syndrome in absence of early therapy. MDPI 2022-08-30 /pmc/articles/PMC9496914/ /pubmed/36138901 http://dx.doi.org/10.3390/brainsci12091165 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Hadjivassiliou, Marios Manto, Mario Mitoma, Hiroshi Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges |
title | Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges |
title_full | Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges |
title_fullStr | Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges |
title_full_unstemmed | Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges |
title_short | Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges |
title_sort | rare etiologies in immune-mediated cerebellar ataxias: diagnostic challenges |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496914/ https://www.ncbi.nlm.nih.gov/pubmed/36138901 http://dx.doi.org/10.3390/brainsci12091165 |
work_keys_str_mv | AT hadjivassilioumarios rareetiologiesinimmunemediatedcerebellarataxiasdiagnosticchallenges AT mantomario rareetiologiesinimmunemediatedcerebellarataxiasdiagnosticchallenges AT mitomahiroshi rareetiologiesinimmunemediatedcerebellarataxiasdiagnosticchallenges |